Fumonisin FB1 treatment acts synergistically with methyl donor deficiency during rat pregnancy to produce alterations of H3- and H4-histone methylation patterns in fetuses

Molecular Nutrition and Food Research

Volumn 56, Issue 6, 2012, Pages 976-985

  Pellanda, Hélène ^a   Forges, Thierry ^a   Bressenot, Aude ^a   Chango, Abalo ^a   Bronowicki, Jean Pierre ^a   Guéant, Jean Louis ^a   Namour, Fares ^a  

^a UNIVERSITÉ DE LORRAINE   (France)

Author keywords

Epigenetic modifications; Folates; Fumonisin; Methyl donor deficiency; Prenatal nutrition

Indexed keywords

FOLATE TRANSPORTER; FOLIC ACID; FUMONISIN; FUMONISIN B1; HISTONE; MESSENGER RNA; TERATOGENIC AGENT;

ANIMAL; ARTICLE; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; CONGENITAL MALFORMATION; CYANOCOBALAMIN DEFICIENCY; DRUG EFFECT; FATTY LIVER; FEMALE; FOLIC ACID DEFICIENCY; GENE EXPRESSION REGULATION; GENETICS; HETEROCHROMATIN; LIVER; MATERNAL NUTRITION; METABOLISM; METHYLATION; NEURAL TUBE DEFECT; PATHOLOGY; PATHOPHYSIOLOGY; PREGNANCY; PRENATAL DEVELOPMENT; RAT; VITAMIN DEFICIENCY; WISTAR RAT;

ABNORMALITIES, DRUG-INDUCED; ANIMALS; CHOLINE DEFICIENCY; FATTY LIVER; FEMALE; FOLIC ACID; FOLIC ACID DEFICIENCY; FOLIC ACID TRANSPORTERS; FUMONISINS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HETEROCHROMATIN; HISTONES; LIVER; MATERNAL NUTRITIONAL PHYSIOLOGICAL PHENOMENA; METHYLATION; NEURAL TUBE DEFECTS; PREGNANCY; RATS; RATS, WISTAR; RNA, MESSENGER; TERATOGENS; VITAMIN B 12 DEFICIENCY;

EID: 84862551081     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201100640     Document Type: Article

References (51)

1. Rheeder, J. P., Marasas, W. F. O., Vismer, H. F., Production of fumonisin analogs by Fusarium species. Appl. Environ. Microbiol. 2002, 68, 2101-2105.
2. Gelderblom, W. C. A., Jaskiewicz, K., Marasas, W. F. O., Thiel, P. G. et al., Fumonisins-novel mycotoxins with cancer-promoting activity produced by Fusarium moniliforme. Appl. Environ. Microsc. 1988, 54, 1806-1811.
3. Gelderblom, W.C.A., Kriek, N.P., Marasas, W.F.O., Thiel, P.G., Toxicity and carcinogenicity of the Fusarium moniliforme metabolite, fumonisin B1, in rats. Carcinogenesis 1991, 12, 1247-1251.
4. Howard, P. C., Eppley, R. M., Stack, M. E., Warbritton, A. et al., Fumonisin b1 carcinogenicity in a two-year feeding study using F344 rats and B6C3F1 mice. Environ. Health Perspect. 2001, 109, 277-282.
5. Marasas, W. F. O., Discovery and occurrence of the Fumonisins: a historical perspective. Environ. Health Perspect. 2001, 109, 239-243.
6. Chu, F. S., Li, G. Y., Simultaneous occurrence of Fumonisin B1 and other mycotoxins in moldy corn collected from the People's Republic of China in regions with high incidences of esophageal cancer. Appl. Environ. Microbiol. 1994, 60, 847-852.
7. Kimanya, M. E., De Meulenaer, B., Roberfroid, D., Lachat, C. et al., Fumonisin exposure through maize in complementary foods is inversely associated with linear growth of infants in Tanzania. Mol. Nutr. Food Res. 2010, 54, 1-9.
8. Missmer, S. A., Suarez, L., Felkner, M., Wang, E. et al., Exposure to fumonisins and the occurrence of neural tube defects along the Texas-Mexico border. Environ. Health Perspect. 2006, 114, 237-241.
9. Gelineau-van Waes, J., Voss, K. A., Stevens, V. L., Speer, M. C. et al., Maternal fumonisin exposure as a risk factor for neural tube defects. Adv. Food Nutr. Res. 2009, 56, 145-181.
10. Marasas, W. F., Riley, R. T., Hendricks, K. A., Stevens, V. L. et al., Fumonisins disrupt sphingolipid metabolism, folate transport, and neural tube development in embryo culture and in vivo: a potential risk factor for human neural tube defects among populations consuming fumonisin-contaminated maize. J. Nutr. 2004, 134, 711-716.
11. Abdel Nour, A. M., Ringot, D., Guéant, J. L., Chango, A., Folate receptor and human reduced folate carrier expression in HepG2 cell line exposed to fumonisin B1 and folate deficiency. Carcinogenesis 2007, 28, 2291-2297.
12. 1 and its alkaline hydrolysis product in LM/Bc mice: hydrolyzed fumonisin B1 did not cause neural tube defects. Toxicol. Sci. 2009, 112, 459-467.
13. Gelineau-van Waes, J., Starr, L., Maddox, J., Aleman, F. et al., Maternal fumonisin exposure and risk for neural tube defects: mechanisms in an in vivo mouse model. Birth Defects Res. A Clin. Mol. Teratol. 2005, 73, 487-497.
14. Matherly, L. H., Membrane transport of folates. Vitam. Horm. 2003, 66, 403-456.
15. 1-induced sphingolipid depletion inhibits vitamin uptake via the glycosylphosphatidylinositol-anchored folate receptor. J. Biol. Chem. 1997, 272, 18020-18025.
16. Sadler, T. W., Merrill, A. H., Stevens, V. L., Sullards, M. C. et al., Prevention of fumonisin B1-induced neural tube defects by folic acid. Teratology 2002, 66, 169-176.
17. Lo Magro, S., Campaniello, M., Nardiello, D., Muscarella, M., Assessment of Fumonisins B1 and B2 levels in commercial maize-based food products by liquid chromatography with fluorimetric detection and postcolumn chemical derivatization. J. Food Sci. 2011, 76, T1-T4.
18. Hirst, M., Marra, M. A., Epigenetics and human disease. Int. J. Biochem. Cell Biol. 2009, 41, 136-146.
19. Smith, D. A., Kim, Y. I., Refsum, H., Is folic acid good for everyone? Am. J. Clin. Nutr. 2008, 87, 517-533.
20. Daxinger, L., Whitelaw, E., Transgenerational epigentic inheritance: more questions than answers. Genome Res. 2010, 20, 1623-1628.
21. Pogribny, I. P., Ross, S. A., Tryndyak, V. P., Pogribna, M. et al., Histone H3 lysine 9 and H4 lysine 20 trimethylation and the expression of Suv-20h2 and Suv-39h1 histone methyltransferases in hepatocarcinogenesis induced by methyl deficiency in rats. Carcinogenesis 2006, 27, 1180-1186.
22. Katayama, M., Matsuda, Y., Shimokawa, K., Tanabe, S. et al., Simultaneous determination of six adenyl purines in human plasma by high-performance liquid chromatography with fluorescence derivatization. J. Chrom. B. Biomed. Sci. Appl. 2001, 760, 159-163.
23. Delabar, U., Kloor, D., Luippold, G., Muhlbauer, B., Simultaneous determination of adenosine, S-adenosylhomocysteine and S-adenosylmethionine in biological samples using solid-phase extraction and high-performance liquid chromatography. J. Chrom. B. Biomed. Sci. Appl. 1999, 724, 231-238.
24. Kleiner, D. E., Brunt, E. M., Natta, M. V., Behling, C. et al., Design and validation of a histological scoring system for non alcoholic fatty liver disease. Hepatology 2005, 41, 1313-1321.
25. Livak, K. J., Schmittgen, T. D., Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)). Methods 2001, 25, 402-408.
26. Shechter, D., Dormann, H. L., Allis, C. D., Hake, S. B., Extraction, purification and analysis of histones. Nat. Protoc. 2007, 2, 1445-1457.
27. Schotta, G., Lachner, M., Sarma, K., Ebert, A. et al., A silencing pathway to induce H3-K9 and H4-K20 trimethylation at constitutive heterochromatin. Gene. Dev. 2004, 18, 1251-1262.
28. Kirmizis, A., Santos-Rosa, H., Penkett, C. J., Singer, M. A. et al., Arginine methylation at histone H3R2 controls deposition of H3K4 trimethylation. Nature 2007, 449, 928-932.
29. Johnson, A., Li, G., Sikorski, T. W., Buratowski, S. et al., Reconstitution of heterochromatin-dependent transcriptional gene silencing. Mol. Cell. 2009, 35, 769-781.
30. McMullen, S., and Langley-Evans, S. C., Maternal low-protein diet in rat pregnancy programs blood pressure through sex-specific mechanisms. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2004, 288, R85-R90.
31. Blaise, S., Alberto, J. M., Nédélec, E., Ayav, A. et al., Mild neonatal hypoxia exacerbates the effects of vitamin-deficient diet on homocysteine metabolism in rats. Pediatric Res, 2005, 57, 777-782.
32. Blaise, S., Nédélec, E., Schroeder, H., Alberto, J. M. et al., Gestational vitamin B deficiency leads to homocysteine-associated brain apoptosis and alters neurobehavioral development in rats. Am. J. Pathol. 2007, 170, 667-679.
33. Ifergan, I., Assaraf, Y. G., Molecular mechanisms of adaptation to folate deficiency. Vitam. Horm. 2008, 79, 99-143.
34. Grewal, S. I., Jia, S., Heterochromatin revisited. Nat. Rev. Genet. 2007, 8(1), 35-46.
35. Yang, H., Mizzen, C. A., The multiple facets of histone H4-lysine 20 methylation. Biochem. Cell Biol. 2009, 87, 151-161.
36. Liu, J. J., Ward, R. L., Folate and one-carbon metabolism and its impact on aberrant DNA methylation in cancer. Adv. Genet. 2010, 71, 79-121.
37. Zeng, W., Ball, A. R., Jr., Yokomori, K., HP1: heterochromatin binding proteins working the genome. Epigenetics 2010, 5, 287-292.
38. Black, J. C., Whetstine, J. R., Chromatin landscape: methylation beyond transcription. Epigenetics 2011, 6, 9-15.
39. Kourmouli, N., Jeppesen, P., Mahadevhaiah, S., Burgoyne, P. et al., Heterochromatin and tri-methylated lysine 20 of histone H4 in animals. J. Cell Sci. 2004, 117, 2491-2501.
40. Jhaveri, M. S., Wagner, C., Trepel, J. B., Impact of extracellular folate levels on global gene expression. Mol. Pharmacol. 2001, 60, 1288-1295.
41. Green, N. D. E., Stanier, P. Moore, G., The emerging role of epigenetic mechanisms in the etiology of neural tube defects. Epigenetics 2011, 6, 875-883.
42. Ichi, S., Costa, F. F., Bischof, J. M., Nakasaki, H. et al., Folic acid remodels chromatin on Hes1 and Neurog2 promoters during caudal neural tube development. J. Biol. Chem. 2010, 285, 36922-36932.
43. Yao, T. P., Oh, S. P., Fuchs, M., Zhou, N. D. et al., Gene dosage dependent embryonic development and proliferation defects in mice lacking the transcriptional intergrator p300. Cell 1998, 93, 361-372.
44. Yin, Z., Haynie, J., Yang, X., Han, B. et al., The essential role of Cited2, a negative regulatro for HIF-1alpha, in heart development and neurulation. Proc. Natl. Acad. Sci. USA 2002, 99, 10488-10493.
45. Bu, P., Evrard, Y. A., Lozano, G., Dent, S. Y., Loss of GCN5 acetyltransferase activity leads to neural tube closure defects and exencephaly in mouse embryos. Mol. Cell. Biol. 2007, 27, 3405-34016.
46. Lin, W., Zhang, Z., Srajer, G., Chen, Y.C., Proper expression of the Gcn5 histone acetyltransferase is required for neural tube closure in mouse embryos. Dev. Dyn. 2008, 237, 928-940.
47. Montgomery, R. L., Hsieh, J., Barbosa, A. C., Richardson, J. A. et al., Histone deacetylases 1 and 2 control the progression of neural precursors to neurons during brain development. Proc. Natl. Acad. Sci. USA 2009, 106, 7876-7881.
48. Vega, R. B., Matsuda, K., Oh, J., Barbosa, A. C. et al., Histone deacetylase 4 controls chondrocyte hypertrophy during skeletogenesis. Cell 2004, 119, 555-566.
49. Cheng, H. L., Mostoslavsky, R., Saito, S., Manis, J. P. et al., Developmental defects and p53 hyperacetylation in Sir2 homolog (SIRT1)-deficient mice. Proc. Natl. Acad. Sci. USA 2003, 100, 10794-10799.
50. Finnell, R. H., Gelineau-van Waes, J., Eudy, J. D., Rosenquist, T. H., Molecular basis of environmentally induced birth defects. Annu. Rev. Pharmacol. Toxicol. 2002, 42, 181-208.
51. Menegola, E., Di Renzo, F., Broccia, M. L., Prudenziati, M., et al., Inhibition of histone deacetylase activity on specific embryonic tissues as a new mechanism for teratogenicity. Birth Defects Res. B Dev. Reprod. Toxicol. 2005, 74, 392-398.